Aptevo Therapeutics - Expected to enter the Apvo451's IND activation research in the first half of 2027
2026-09-24 20:13:09
According to CoinMeta, as reported by Reuters, Aptevo Therapeutics is expected to enter the IND research phase of Apvo451 in the first half of 2027.
Bullish 0
Bearish 0
Source:Internet
This content is for market information only and does not constitute investment advice.